Top 5 Biotechnology Angel Investors in New Zealand in January 2026
A list of 5 angel investors that invest in Biotechnology startups based in New zealand. We rank investors based on the number of investments they made in Biotechnology companies from New zealand. We update this investor list every month.Top 5 Biotechnology Angel Investors in New Zealand in January 2026
| Investor | Biotechnology New Zealand investments |
|---|---|
| Paul Davidson | 1 |
| Marko Bogoievski | 1 |
| Serge van Dam | 1 |
| Melanie Melanie | 1 |
| David Ross | 1 |
Paul Davidson joined private equity group, West Coast Capital in 2005 following a successful career in corporate law in the UK, the US and Commonwealth of Independent States. As an active partner in West Coast Capital as well as providing legal counsel, Paul focusses on deal sourcing and transacting.Since joining the group, Paul has successfulyled the acquisition and delisting from the LSE of the UK's largest garden centre business, Wyevale as well as a series of acquisitions and disposals.Prior to joining West Coast Capital headed the corporate team of UK lawyers, McGrigors.In late 1994 Paul was seconded to an oil and gas company called JKX whose focus was on the former Soviet Union, primarily in Ukraine, Georgia and the Russian Federation. JKX listed on the London Stock Exchange in mid 1995 and at that time Paul joined the company as its Legal Director on a full time basis. During his time as Legal Director, Paul gained wide commercial experience as the company concluded a number of transactions throughout the former Soviet Union.
Show more
Investment focus
- SaaS, FinTech, Privacy
- Seed, Series A, Series B
- Finland, New Zealand, United Kingdom
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
- TVSquared — With trusted, independent attribution and partnerships with DSPs, publishers, advertisers and MVPDs, TVSquared measures the effectiveness of TV advertising through an infinitely scalable platform for linear, addressable and OTT/CTV.
- Ubisecure — Ubisecure B2B IAM, Legal Entity Identifiers LEI, IDaaS and hybrid identity management. European SSO, MFA, LEI made easy.
Marko retired as CEO of Morrison & Co in 2021 after 13 years of leading the business. He continues to provide guidance for investments in telecommunications and digital infrastructure. His 30 year career has been in the infrastructure and technology sectors in a variety of senior finance, operational and sales roles in the United States and NewZealand. Prior to joining Morrison & Co in 2008, Marko was CFO of Telecom NZ, responsible for corporate finance, M&A and group strategy. Marko is Chair of Vodafone New Zealand.
Show more
Investment focus
- Biotechnology, Manufacturing
- Funding Round
- New Zealand
Portfolio highlights
- Pictor — PictorDx offers a flexible multiplex proteomics platform that delivers multiple biomarker insights simultaneously and cost-effectively for multiple sample types
Serge has a depth of experience in technology startups that is difficult to rival. As CMO of M-Com, Serge led the growth of M-Com from a four person mobile commerce development company to the world's most successful provider of mobile banking and payment solutions (in both licensed and SaaS categories). He has since held executive levelpositions and Directorships, including as Chair on four boards, of many successful B2B SaaS companies. He is also an avid investor.
Show more
Investment focus
- Biotechnology, Product Research
- Seed
- New Zealand
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
Investor
Show more
Investment focus
- Biotechnology, Product Research
- Seed
- New Zealand
Portfolio highlights
- Daisy Lab — Daisy Lab pioneers precision fermentation technology in New Zealand
David Ross
Show more
Investment focus
- Biopharma, Biotechnology
- Seed
- New Zealand
Portfolio highlights
- Helico — Helico is developing a proprietary computational platform for synthetic biology research using modelling tools and AI-based prediction algorithms. The long-term aim is to develop a seed bank of different drugs able to be licensed to grow medical supplies in confined greenhouses anywhere in the world.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Art
Wellness
Web3
Android
Organic Food
Digital Media
Manufacturing
Big Data
Construction
Sports
Video Games
Franchise
Publishing
eSports
Mobile
Enterprise Software
B2B
Music
Email
Social Media
Food and Beverage
Social Network
Medical
Payments
Legal
Local
Internet
Real Estate
Biotechnology
Travel
Fitness
Recruiting
Hospitality
Finance
Mobile Advertising
Platforms
Cannabis
Automotive
Social
Wine And Spirits
Medical Device
Crowdfunding
Education
CleanTech
Mobile Apps
Transportation
Financial Services
InsurTech
Enterprise
Retail
LGBT
Infrastructure
Beauty
Photography
Film
Oil and Gas
Fashion
Life Science
Theatre
Non Profit
Renewable Energy
SaaS
Restaurants
Sporting Goods
Software
Celebrity
Social Impact
Cryptocurrency
Facebook
Machine Learning
Agriculture (agtech)
Media (entertainment)
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Ghana
Qatar
Egypt
Japan
Belarus
Hungary
Singapore
Finland
France
Croatia
Spain
Gibraltar
Barbados
Georgia
Greece
China
Czech Republic
Armenia
Faroe Islands
Costa Rica
Hong Kong
Saudi Arabia
Bahrain
Belgium
Denmark
Oceania
Bermuda
Estonia
Algeria
Africa
Ecuador
Bulgaria
Belize
Chile
LATAM
Ethiopia
Liechtenstein
Panama
Myanmar
Lithuania
Malaysia
Peru
Liberia
Jersey
Lebanon
Asia
Norway
Mexico
Italy
Mali
Philippines
Israel
Kuwait
Mauritius
Brazil
Malta
Morocco
Nicaragua
Togo
Rwanda
Slovenia
Poland
Dominican Republic
Uganda
San Marino
Sweden
Bahamas
Serbia
Sierra Leone
Thailand
Tanzania
Uzbekistan
Zambia
Turkey
Uruguay
Tajikistan
Russian Federation
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Ukraine
Taiwan
United Arab Emirates
Jamaica
Iraq
Honduras
Isle of Man
Bolivia
Iceland
Luxembourg
Pakistan
Albania
Azerbaijan
Romania
Jordan
Grenada
Argentina
Bangladesh
Nigeria
Namibia
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Colombia
Guatemala
Seychelles
Marshall Islands
Angel Investors in New Zealand by industry
Proptech
SaaS
Marketplace
Climate
Enterprise Software
Mobile Apps
Real Estate
Web3
Enterprise
Internet
Software
Biotechnology
FinTech
Artificial intelligence
Education
EdTech
Consumer
Platforms
Blockchain
Health Care
Financial Services
Biotech
Hardware
Transportation
Media (entertainment)
Payments
Facebook
Machine Learning
Mobile
Community
Gaming